Delivery Order SPE2DR25D1017-SPE2DR26F9CMH
Award Date 1/2/26
Potential Completion Date 1/5/26
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,037.10 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a prescription migraine treatment medication, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $22,286.82 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packaging) on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price, non-set-aside contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,875.81 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100 unit dose packages of 10 tablets each) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside purchase and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide...
- The Defense Logistics Agency awarded a delivery order valued at $1,804.46 to AmerisourceBergen Drug Corp for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. UBRELVY is a calcitonin gene-related peptide receptor antagonist used for the acute...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,603.68 to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (100 unit-dose packs) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a prescription medication used for acute...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.73 to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (10-count unit dose packages) on September 29, 2025, with completion scheduled for September 30, 2025. This competitively awarded, non-set-aside delivery order uses firm fixed pricing and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used for acute...
- The Defense Logistics Agency awarded a delivery order valued at $5,427.25 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablet unit dose packs (16 count). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 25, 2025. UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist indicated for acute migraine treatment. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $13,431.90 delivery order to AmerisourceBergen Drug Corp for UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging of 10 tablets on April 24, 2025, with completion targeted for April 25, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $2,199.96 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10 unit dose packages) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- The Defense Logistics Agency awarded a delivery order valued at $10,656.48 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unidose, 16-count packaging) on December 23, 2025, with completion scheduled for December 24, 2025. This competitive award, made without set-aside designation, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...